Long-term expression of von Willebrand factor by a VSV-G pseudotyped lentivirus enhances the functional activity of secreted B-domain-deleted coagulation factor VIII

Sang Won Park, Sang-Yun Choi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

von Willebrand factor (vWF) is a multimeric glycoprotein which functions within the coagulation system. It colocatizes with factor VIII (FVIII) by non-covalent interaction and alters its intracellular trafficking. vWF is also instrumental in maintaining the stability of secreted FVIII. The principal objective of this study was to generate a lentivirus-based vWF expression vector for gene therapy of hemophilia A. We inserted a vWF of 8.8 Kb into a lentiviral vector thereby producing VSV-G-pseudotyped vEx52. However, its titer was quite low, presumably because the length of vWF gene exceeds the size limit of the lentiviral vector. In order to overcome the low-titer, we concentrated the vEx52 and thus increased the efficiency of transduction approximately 6-fold with 1/100th of the volume. However, as concentration requires an additional laborious step, we attempted to enhance the transduction efficiency by deleting exons 24-46 and 29-46 in pRex52 to construct pRex23 and pRex28, and in pvEx52, yielding pvEx23 and pvEx28, respectively. The transfected. pRex52 had a profound effect on the activity of secreted FVIII, and this activity declined as domains of vWF were deleted. However, when the domain-deleted vWF-lentiviruses were transduced into K562 cells, the vEx28 increased the activity of the secreted FVIII compared to what was observed with vEx52. This result is probably due to higher efficiencies of transduction and expression while retaining the essential domains required for proper interaction with FVIII.

Original languageEnglish
Pages (from-to)125-131
Number of pages7
JournalMolecules and Cells
Volume24
Issue number1
Publication statusPublished - 2007 Aug 31

Fingerprint

Lentivirus
Factor VIII
von Willebrand Factor
K562 Cells
Hemophilia A
B-domain-deleted factor VIII
Genetic Therapy
Exons
Glycoproteins
Genes

Keywords

  • Coagulation factor VIII
  • Gene therapy
  • Lentivirus
  • von Willebrand factor

ASJC Scopus subject areas

  • Cell Biology
  • Genetics
  • Molecular Biology

Cite this

@article{6abf71b9a53443609ee39031d0963b3c,
title = "Long-term expression of von Willebrand factor by a VSV-G pseudotyped lentivirus enhances the functional activity of secreted B-domain-deleted coagulation factor VIII",
abstract = "von Willebrand factor (vWF) is a multimeric glycoprotein which functions within the coagulation system. It colocatizes with factor VIII (FVIII) by non-covalent interaction and alters its intracellular trafficking. vWF is also instrumental in maintaining the stability of secreted FVIII. The principal objective of this study was to generate a lentivirus-based vWF expression vector for gene therapy of hemophilia A. We inserted a vWF of 8.8 Kb into a lentiviral vector thereby producing VSV-G-pseudotyped vEx52. However, its titer was quite low, presumably because the length of vWF gene exceeds the size limit of the lentiviral vector. In order to overcome the low-titer, we concentrated the vEx52 and thus increased the efficiency of transduction approximately 6-fold with 1/100th of the volume. However, as concentration requires an additional laborious step, we attempted to enhance the transduction efficiency by deleting exons 24-46 and 29-46 in pRex52 to construct pRex23 and pRex28, and in pvEx52, yielding pvEx23 and pvEx28, respectively. The transfected. pRex52 had a profound effect on the activity of secreted FVIII, and this activity declined as domains of vWF were deleted. However, when the domain-deleted vWF-lentiviruses were transduced into K562 cells, the vEx28 increased the activity of the secreted FVIII compared to what was observed with vEx52. This result is probably due to higher efficiencies of transduction and expression while retaining the essential domains required for proper interaction with FVIII.",
keywords = "Coagulation factor VIII, Gene therapy, Lentivirus, von Willebrand factor",
author = "Park, {Sang Won} and Sang-Yun Choi",
year = "2007",
month = "8",
day = "31",
language = "English",
volume = "24",
pages = "125--131",
journal = "Molecules and Cells",
issn = "1016-8478",
publisher = "Korean Society for Molecular and Cellular Biology",
number = "1",

}

TY - JOUR

T1 - Long-term expression of von Willebrand factor by a VSV-G pseudotyped lentivirus enhances the functional activity of secreted B-domain-deleted coagulation factor VIII

AU - Park, Sang Won

AU - Choi, Sang-Yun

PY - 2007/8/31

Y1 - 2007/8/31

N2 - von Willebrand factor (vWF) is a multimeric glycoprotein which functions within the coagulation system. It colocatizes with factor VIII (FVIII) by non-covalent interaction and alters its intracellular trafficking. vWF is also instrumental in maintaining the stability of secreted FVIII. The principal objective of this study was to generate a lentivirus-based vWF expression vector for gene therapy of hemophilia A. We inserted a vWF of 8.8 Kb into a lentiviral vector thereby producing VSV-G-pseudotyped vEx52. However, its titer was quite low, presumably because the length of vWF gene exceeds the size limit of the lentiviral vector. In order to overcome the low-titer, we concentrated the vEx52 and thus increased the efficiency of transduction approximately 6-fold with 1/100th of the volume. However, as concentration requires an additional laborious step, we attempted to enhance the transduction efficiency by deleting exons 24-46 and 29-46 in pRex52 to construct pRex23 and pRex28, and in pvEx52, yielding pvEx23 and pvEx28, respectively. The transfected. pRex52 had a profound effect on the activity of secreted FVIII, and this activity declined as domains of vWF were deleted. However, when the domain-deleted vWF-lentiviruses were transduced into K562 cells, the vEx28 increased the activity of the secreted FVIII compared to what was observed with vEx52. This result is probably due to higher efficiencies of transduction and expression while retaining the essential domains required for proper interaction with FVIII.

AB - von Willebrand factor (vWF) is a multimeric glycoprotein which functions within the coagulation system. It colocatizes with factor VIII (FVIII) by non-covalent interaction and alters its intracellular trafficking. vWF is also instrumental in maintaining the stability of secreted FVIII. The principal objective of this study was to generate a lentivirus-based vWF expression vector for gene therapy of hemophilia A. We inserted a vWF of 8.8 Kb into a lentiviral vector thereby producing VSV-G-pseudotyped vEx52. However, its titer was quite low, presumably because the length of vWF gene exceeds the size limit of the lentiviral vector. In order to overcome the low-titer, we concentrated the vEx52 and thus increased the efficiency of transduction approximately 6-fold with 1/100th of the volume. However, as concentration requires an additional laborious step, we attempted to enhance the transduction efficiency by deleting exons 24-46 and 29-46 in pRex52 to construct pRex23 and pRex28, and in pvEx52, yielding pvEx23 and pvEx28, respectively. The transfected. pRex52 had a profound effect on the activity of secreted FVIII, and this activity declined as domains of vWF were deleted. However, when the domain-deleted vWF-lentiviruses were transduced into K562 cells, the vEx28 increased the activity of the secreted FVIII compared to what was observed with vEx52. This result is probably due to higher efficiencies of transduction and expression while retaining the essential domains required for proper interaction with FVIII.

KW - Coagulation factor VIII

KW - Gene therapy

KW - Lentivirus

KW - von Willebrand factor

UR - http://www.scopus.com/inward/record.url?scp=35048899179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35048899179&partnerID=8YFLogxK

M3 - Article

C2 - 17846507

AN - SCOPUS:35048899179

VL - 24

SP - 125

EP - 131

JO - Molecules and Cells

JF - Molecules and Cells

SN - 1016-8478

IS - 1

ER -